Viral Vector Manufacturing Market Is Expected To Demonstrate Strong Growth by Forecast to 2028
Viral Vector Manufacturing Market
Overview:
Viral vector manufacturing refers to the production of a
carrier called a vector which is genetically engineered to deliver the gene
because they can deliver the new gene by infecting the cell. Considered as a drug substance, viral vectors
are used in gene therapy and vaccinology (vaccines). In the case of cell
therapies, the scrutiny for testing for adventitious agents is high.
Viruses that are often used as vectors include retroviruses
that integrate their genetic material including the new gene in the human cell,
and adenoviruses, that introduce their DNA into the nucleus of the cell without
letting the DNA to integrate into a chromosome. These viruses are modified so
they can't cause disease when used in people.
Gene therapy has seen various clinical advancement, and
along with it, the Viral
Vector Manufacturing Market is growing pervasively. Gene therapy is one
of the most preferred treatment options for a number of chronic diseases. Over
the past few years, the viral vector manufacturing market is growing rapidly
mainly due to the growing prevalence of devastating neurodegenerative diseases
including Parkinson’s, Alzheimer’s, and ALS.
Acknowledging the exponential accruals, the market is
witnessing currently, Market Research Future (MRFR) in its recently published
study report asserts that the global viral vector manufacturing market will garner
a value of USD 319 MN by 2023, registering a whopping CAGR of approx. 22.65%
throughout the forecast period (2018-2023).
The increasing number of clinical trials and the growing
necessity for an effective mode of disease treatment are some of the factors
fostering the growth of the market. Additional factors having a synergistic
effect on the growth of the viral vector manufacturing market include the
increasing number of technological advancements, a growing number of ambulatory
services, and government initiatives.
On the flip side, factors such as the high cost of gene
therapies and possible mutagenesis alongside the strict government regulation
and time-consuming approval process are expected to impede market growth.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/6890
Global Viral Vector Manufacturing Market – Segmentations
The MRFR analysis is segmented into five key dynamics for
enhanced understanding.
By Type: Retroviral Vectors, Adeno-Associated Viral
Vectors, and Adenoviral Vectors among others.
By Disease: Cancer, Genetic Disorders and Infectious
Diseases among others.
By Application: Gene Therapy and Vaccinology among others.
By End-user : Pharmaceutical Companies, Biotechnology
Companies, and Research Institutes, among others.
By Regions: Asia Pacific, North America, Europe, and
the Rest-of-the-World.
Global Viral Vector Manufacturing Market - Regional
Analysis
The North American Region heading with the growing
prevalence of autoimmune and chronic diseases, accounts for the leading market
for viral vector manufacturing, globally. Moreover, technological advancements
in the manufacturing of these vectors is a key force driving the growth of this
market.
Additionally, favorable reimbursement policies and the
presence of well-developed healthcare infrastructure, and increasing geriatric
population are some of the key driving forces contributing to the growth of the
regional market.
The U.S., backed by a large number of patients suffering
from Alzheimer’s and Parkinson's diseases, majorly contributes to an increase
in the demand for viral vectors in the region. Moreover, factors such as the
high healthcare expenditures alongside the availability of viruses required for
the production of these vectors and technological expertise drive the growth of
the regional market.
The European region, led by the well-established R&D
sector accounts for the second-largest market for viral vector
manufacturing. Besides, factors such as
the availability of funds for research and increasing healthcare expenditures
drive the regional market. Moreover, the increase in occurrences of chronic
diseases has led to the rise in the market growth in the region. Also, the
presence of a developed healthcare sector and the resurging economy in the
region foster the growth of the viral vector manufacturing market in Europe.
The viral vector manufacturing market in the Asia Pacific
region is emerging as a promising market owing to the huge patient population
suffering from diseases such as Parkinson’s, Alzheimer’s, and ALS.
Moreover, continuously growing healthcare sector led by the
rapid economic growth in the APAC that is increasing the per capita healthcare
expenses is a dominant driving force behind the growth of the regional market.
Recent economic data suggests that China along with Southeast Asia is expected
to join the ranks of the deep-pocketed Asian economies such as Taiwan and
Korea.
China, owing to the presence of a huge geriatric population
leads the viral vector manufacturing market in the APAC. Whereas, India due to
the vast population base, rapidly changing economy, and the increasing number
of manufacturers of these vectors, accounts for the second largest market in
the region.
Whereas, the Middle East & Africa (MEA)region has the
least market share due to the lack of awareness and low healthcare
expenditures. The viral vector manufacturing market in the MEA region will
exhibit moderate growth during the corresponding period.
Global Viral Vector Manufacturing Market - Competitive Analysis
The structure of the viral vector manufacturing market is
changing due to the acquisition of local manufactures by multinational
companies. Due to the increasing competition in the market, multination
companies are using the strategy of acquisition, which has increased the profit
of the company as well as significantly reduced the competition.
Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/viral-vector-manufacturing-market-6890
Major Players:
Key players leading the global viral vector manufacturing
market include Sanofi, Lonza, FUJIFILM Diosynth Biotechnologies U.S.A., Inc.,
Merck KGaA, General Electric Company, uniQure N.V., Oxford BioMedica, Spark
Therapeutics, Inc., FinVector Vision Therapies, Cobra Biologics, Brammer Bio,
Cell and Gene Therapy Catapult, REGENXBIO Inc., and Kaneka Eurogentec S.A.
among others.
Industry/Innovation/Related News:
February 04, 2019 ---- SIRION BIOTECH GmbH (Germany), a
leading global company providing the most comprehensive viral vector production
and customization services announced its expansion in North America, hosting a
Bavarian-themed grand opening event at the Forsyth Institute, the US to meet
and mingle with the Cambridge gene therapy scene.
During the event, SIRION also mentioned that Gene therapy
has seen robust clinical advancement and Sirion is becoming a preferred partner
in this growing sector.
January 28, 2019 ---- SIRION BIOTECH GmbH (Germany), a
leading global company providing the most comprehensive viral vector production
and customization services announced its partnership with Denali Therapeutics
to support local gene therapy research and clinical development with viral
vector contract manufacturing. The licensing agreement is about developing a
new generation of adeno-associated virus (AAV) vectors.
This ground-breaking licensing agreement (collaboration) is
expected to help Denali Therapeutics to increase the availability of protein
therapeutics and to quickly enter clinical trials with safe, efficient, and
scalable therapeutic candidates.
While, this partnership with Denali, will help Sirion to
send its CNS-directed AAV-based gene therapies to the market in the fastest way
possible, providing advanced treatment options to millions of patients,
worldwide.
At Market Research Future (MRFR), we enable our customers
to unravel the complexity of various industries through our Cooked Research
Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by
Components, Application, Logistics and market players for global, regional, and
country level market segments, enable our clients to see more, know more, and
do more, which help to answer all their most important questions.
Contact:
Market Research Future®
99 Hudson Street,5Th Floor
New York, New York 10013
United States of America
Phone:
+1 628 258 0071(US)
+44 2035 002 764(UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
Comments
Post a Comment